EKTAB N Stock Overview
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Elekta AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr126.26 |
52 Week High | kr145.92 |
52 Week Low | kr116.44 |
Beta | 1.03 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -14.06% |
3 Year Change | -53.81% |
5 Year Change | n/a |
Change since IPO | -56.57% |
Recent News & Updates
Recent updates
Shareholder Returns
EKTAB N | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | -14.1% | 0% | 0% |
Return vs Industry: EKTAB N underperformed the MX Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: EKTAB N underperformed the MX Market which returned 2.4% over the past year.
Price Volatility
EKTAB N volatility | |
---|---|
EKTAB N Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: EKTAB N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EKTAB N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 4,584 | Gustaf Salford | elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care.
Elekta AB (publ) Fundamentals Summary
EKTAB N fundamental statistics | |
---|---|
Market cap | Mex$46.13b |
Earnings (TTM) | Mex$2.25b |
Revenue (TTM) | Mex$28.59b |
20.5x
P/E Ratio1.6x
P/S RatioIs EKTAB N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EKTAB N income statement (TTM) | |
---|---|
Revenue | kr18.22b |
Cost of Revenue | kr11.32b |
Gross Profit | kr6.90b |
Other Expenses | kr5.47b |
Earnings | kr1.43b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
Jun 05, 2024
Earnings per share (EPS) | 3.75 |
Gross Margin | 37.88% |
Net Profit Margin | 7.86% |
Debt/Equity Ratio | 57.2% |
How did EKTAB N perform over the long term?
See historical performance and comparison